Series Preface |
|
xix | |
Preface |
|
xxi | |
The Author |
|
xxiii | |
Section I Introduction |
|
|
|
1 | (10) |
|
Guidelines and Interpretation of Data |
|
|
6 | (1) |
|
Quality Assurance and Quality Control |
|
|
7 | (1) |
|
|
7 | (4) |
Section II Vitamins |
|
|
|
|
Vitamin C (Ascorbic Acid) |
|
|
11 | (26) |
|
History of Vitamin C and Scurvy |
|
|
11 | (1) |
|
|
12 | (1) |
|
Occurrence of Vitamin C Deficiency |
|
|
12 | (1) |
|
Dietary Sources of Vitamin C |
|
|
13 | (1) |
|
Vitamin C Functions and Metabolism |
|
|
13 | (1) |
|
Proline and Hydroxyproline and Vitamin C Deficiency |
|
|
14 | (1) |
|
Potential Pharmacological Benefits of Vitamin C |
|
|
15 | (1) |
|
|
15 | (1) |
|
Determination of Vitamin C in Biological Specimens |
|
|
16 | (4) |
|
Assessment of Vitamin C Status |
|
|
20 | (2) |
|
Vitamin C Concentrations in Whole Blood, Red Cells and Leucocytes and Plasma |
|
|
22 | (4) |
|
Urinary Excretion of Vitamin C |
|
|
26 | (1) |
|
Potential New Assessment Methods |
|
|
27 | (1) |
|
Vitamin C Toxicity and Safety |
|
|
27 | (1) |
|
|
27 | (1) |
|
|
28 | (9) |
|
|
37 | (18) |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
38 | (1) |
|
|
38 | (1) |
|
Alcohol and Thiamin Status |
|
|
38 | (1) |
|
Assessment of Thiamin Nutritional Status |
|
|
39 | (3) |
|
Erythrocyte Transketolase Assay |
|
|
42 | (1) |
|
Sample Preparation and Storage |
|
|
43 | (1) |
|
Guides for Interpretation of Erythrocyte Transketolase Activity |
|
|
44 | (1) |
|
Blood Thiamin Measurements |
|
|
45 | (1) |
|
Urinary Excretion of Thiamin |
|
|
45 | (2) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (8) |
|
|
55 | (16) |
|
|
55 | (1) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
Riboflavin Nutritional Assessment |
|
|
57 | (1) |
|
Riboflavin Analytical Methods |
|
|
57 | (3) |
|
Erythrocyte Glutathione Reductase Assays |
|
|
60 | (4) |
|
|
64 | (1) |
|
|
64 | (1) |
|
|
65 | (6) |
|
|
71 | (32) |
|
|
71 | (1) |
|
Bioavailability and Source of Vitamin B-6 |
|
|
72 | (1) |
|
Clinical Vitamin B-6 Deficiency |
|
|
72 | (1) |
|
Vitamin B-6 Metabolism and Utilization |
|
|
73 | (1) |
|
Assessment of Vitamin B-6 Nutritional Status |
|
|
74 | (1) |
|
Human Studies of Vitamin B-6 Nutritional Assessment Methods |
|
|
74 | (4) |
|
Pyridoxal 5'-phosphate and Vitamin B-6 Assessment |
|
|
78 | (1) |
|
Determination of Plasma Homocysteine |
|
|
79 | (1) |
|
Determination of Transaminase Activities |
|
|
80 | (2) |
|
Tryptophan Load and Xanthurenic Acid Excretion |
|
|
82 | (1) |
|
|
82 | (1) |
|
Urinary Excretion of 4-Pyridoxic Acid |
|
|
83 | (1) |
|
Urinary Excretion of Vitamin B-6 |
|
|
83 | (1) |
|
|
84 | (6) |
|
|
90 | (1) |
|
|
90 | (1) |
|
|
91 | (12) |
|
Folate (Folic Acid, Pteroylmonoglutamic Acid, Folacin) |
|
|
103 | (32) |
|
|
104 | (1) |
|
|
104 | (1) |
|
|
104 | (1) |
|
Folate Metabolism and Functions |
|
|
105 | (2) |
|
Occurrence of Folate Deficiency |
|
|
107 | (1) |
|
Folate Nutritional Status |
|
|
108 | (1) |
|
Factors Influencing Folate Status |
|
|
109 | (2) |
|
Evaluation of Folate Nutritional Status |
|
|
111 | (4) |
|
Determination of Plasma and Erythrocyte of Folate Concentrations |
|
|
115 | (1) |
|
Folate Status and Homocysteine Metabolism |
|
|
116 | (4) |
|
Hypersegmentation of Neutrophils |
|
|
120 | (1) |
|
Deoxyuridine Suppression Test (dUST) |
|
|
120 | (1) |
|
Formininoglutamic Acid Excretion (FIGLU Test) |
|
|
121 | (1) |
|
Urinary Excretion of Folate |
|
|
122 | (1) |
|
Folate Safety and Toxicity |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
124 | (11) |
|
Vitamin B-12 (Cyanocobalamin, Corrinoids) |
|
|
135 | (26) |
|
|
135 | (1) |
|
Function of Vitamin B-12 (Cobalamin) |
|
|
136 | (1) |
|
|
137 | (1) |
|
|
137 | (1) |
|
Occurrence of Vitamin B-12 Deficiency |
|
|
138 | (1) |
|
|
139 | (1) |
|
Nitrous Oxide and Vitamin B-12 |
|
|
139 | (1) |
|
Laboratory Methods for Assessment of Vitamin B-12 Status |
|
|
140 | (6) |
|
Factors Influencing Vitamin B-12 Status |
|
|
146 | (1) |
|
Interpretation of Vitamin B-12 and Folate Assessment Results |
|
|
147 | (1) |
|
|
147 | (1) |
|
|
148 | (1) |
|
|
149 | (12) |
|
Niacin (Nicotinic Acid, Nicotinamide) |
|
|
161 | (14) |
|
|
161 | (2) |
|
|
163 | (1) |
|
Niacin Deficiency (Pellagra) |
|
|
163 | (1) |
|
|
163 | (1) |
|
Methods for the Assessment of Niacin Status |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
164 | (1) |
|
High-Performance Liquid Chromatography Procedures (HPLC) |
|
|
165 | (1) |
|
Measurement of N'-Methyl-4-Pyridone-5-Carboxamide |
|
|
165 | (1) |
|
Assessment of Niacin Status |
|
|
166 | (2) |
|
Plasma Metabolites and Niacin Status |
|
|
168 | (1) |
|
Pyridine Nucleotides and Niacin Status |
|
|
168 | (1) |
|
Children (10 to 13 Years) |
|
|
168 | (1) |
|
|
169 | (1) |
|
|
169 | (1) |
|
|
170 | (1) |
|
|
170 | (5) |
|
|
175 | (10) |
|
|
175 | (1) |
|
Pantothenic Acid Deficiency |
|
|
175 | (1) |
|
|
176 | (1) |
|
Methods for the Determination of Pantothenic Acid |
|
|
177 | (1) |
|
Assessment of Pantothenic Acid Status |
|
|
178 | (1) |
|
Pantothenic Acid Status in Population Groups |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
181 | (4) |
|
|
185 | (10) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
187 | (1) |
|
|
188 | (1) |
|
Experimental Biotin Deficiency in the Human |
|
|
188 | (2) |
|
|
190 | (1) |
|
|
191 | (1) |
|
|
191 | (4) |
|
|
|
|
195 | (38) |
|
Background/History/Function |
|
|
195 | (2) |
|
|
197 | (1) |
|
Carotenoids: Nutrition and Measurement |
|
|
197 | (1) |
|
|
198 | (1) |
|
|
199 | (2) |
|
Interactions of Vitamin A |
|
|
201 | (2) |
|
Assessment of Vitamin A Nutritional Status |
|
|
203 | (4) |
|
Biochemical Methods for the Assessment of Vitamin A Status |
|
|
207 | (4) |
|
Methods for the Measurement of Vitamin A in Plasma or Serum |
|
|
211 | (1) |
|
|
212 | (1) |
|
Relationship of Plasma Retinol Levels to Vitamin A Status |
|
|
212 | (3) |
|
|
215 | (1) |
|
|
216 | (17) |
|
|
233 | (16) |
|
|
234 | (1) |
|
|
234 | (1) |
|
|
235 | (1) |
|
Vitamin D and the Elderly |
|
|
236 | (1) |
|
Assessment of Vitamin D Status |
|
|
236 | (1) |
|
Measurement of 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D |
|
|
237 | (1) |
|
|
238 | (1) |
|
Osteocalcin and Vitamin D |
|
|
239 | (1) |
|
Vitamin D Absorption Test |
|
|
239 | (1) |
|
|
239 | (1) |
|
Vitamin D: Drug Interaction and Toxicity |
|
|
239 | (1) |
|
|
240 | (1) |
|
|
240 | (2) |
|
Suggested Guidelines for Evaluating Vitamin D Status |
|
|
242 | (1) |
|
|
242 | (7) |
|
|
249 | (18) |
|
|
249 | (1) |
|
|
250 | (1) |
|
|
250 | (1) |
|
|
251 | (1) |
|
Assessment of Vitamin E Status |
|
|
252 | (5) |
|
Vitamin E Status: Functional Procedures |
|
|
257 | (1) |
|
Handling of Blood Specimens |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
258 | (1) |
|
|
259 | (8) |
|
|
267 | (14) |
|
|
267 | (1) |
|
|
268 | (1) |
|
|
269 | (1) |
|
|
270 | (1) |
|
Vitamin K and Anticoagulants |
|
|
270 | (1) |
|
Vitamin K-Dependent Carboxylase |
|
|
271 | (1) |
|
Vitamin K and Bone Formation |
|
|
271 | (1) |
|
Methods for the Assessment of Vitamin K Status |
|
|
272 | (1) |
|
Determination of Vitamin K |
|
|
273 | (1) |
|
Studies on the Assessment of Vitamin K Status |
|
|
274 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
|
275 | (6) |
|
|
|
|
281 | (6) |
|
|
281 | (1) |
|
|
282 | (1) |
|
|
282 | (1) |
|
|
282 | (2) |
|
|
284 | (3) |
|
|
287 | (6) |
|
|
287 | (1) |
|
Choline Requirements and Assessment |
|
|
288 | (1) |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
290 | (3) |
|
|
293 | (2) |
|
|
294 | (1) |
|
|
295 | (6) |
|
Assessment of Taurine Status |
|
|
295 | (1) |
|
|
296 | (1) |
|
|
297 | (1) |
|
|
297 | (4) |
Section III Minerals |
|
|
|
|
Sodium, Potassium, and Chloride |
|
|
301 | (12) |
|
|
301 | (1) |
|
|
302 | (2) |
|
Sample Preparation for Sodium and Potassium Determinations |
|
|
304 | (1) |
|
Urine Measurements of Sodium and Potassium |
|
|
304 | (1) |
|
|
305 | (1) |
|
|
306 | (1) |
|
Sodium, Potassium, and Chloride |
|
|
306 | (1) |
|
|
307 | (1) |
|
|
308 | (5) |
|
|
|
|
313 | (12) |
|
|
313 | (1) |
|
|
314 | (1) |
|
|
315 | (1) |
|
|
315 | (3) |
|
Bone Density Measurements and Calcium Status |
|
|
318 | (1) |
|
Urinary Excretion of Calcium |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
|
320 | (5) |
|
|
325 | (6) |
|
|
325 | (1) |
|
|
326 | (1) |
|
|
326 | (1) |
|
Serum Phosphate Determination |
|
|
326 | (2) |
|
|
328 | (1) |
|
|
328 | (1) |
|
|
328 | (1) |
|
|
329 | (2) |
|
|
331 | (12) |
|
|
331 | (1) |
|
|
331 | (1) |
|
National Health and Nutrition Examination Survey |
|
|
332 | (1) |
|
Evaluation of Magnesium Status |
|
|
332 | (3) |
|
|
335 | (1) |
|
|
336 | (1) |
|
|
336 | (1) |
|
|
336 | (1) |
|
|
337 | (1) |
|
|
337 | (6) |
|
|
|
|
343 | (28) |
|
History of Iron Deficiency |
|
|
343 | (1) |
|
|
343 | (1) |
|
Iron Deficiency and Metabolism |
|
|
344 | (1) |
|
Laboratory Procedures for the Assessment of Iron Status |
|
|
344 | (6) |
|
Factors Influencing the Interpretation of Hematological Data |
|
|
350 | (2) |
|
Iron Deficiency in Population Groups |
|
|
352 | (1) |
|
Iron Deficiency in the Elderly |
|
|
353 | (1) |
|
Iron Status in Volunteer Blood Donors |
|
|
353 | (1) |
|
Iron Assessment of Populations |
|
|
353 | (1) |
|
National Health and Nutrition Examination Surveys |
|
|
354 | (1) |
|
Iron Overload/Iron Toxicity |
|
|
354 | (7) |
|
|
361 | (1) |
|
|
361 | (10) |
|
|
371 | (12) |
|
|
371 | (1) |
|
|
371 | (1) |
|
|
372 | (3) |
|
Assessment of Iodine Nutritional Status |
|
|
375 | (1) |
|
Iodine Excretion Guidelines |
|
|
375 | (1) |
|
|
375 | (2) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
378 | (1) |
|
|
378 | (5) |
|
|
383 | (14) |
|
History of Zinc Essentiality |
|
|
383 | (1) |
|
Occurrence of Zinc Deficiency |
|
|
383 | (2) |
|
Zinc Essentiality and Functions |
|
|
385 | (1) |
|
Diet and Zinc Sources and Intakes |
|
|
385 | (1) |
|
Zinc Nutritional Assessment |
|
|
386 | (4) |
|
|
390 | (1) |
|
|
390 | (1) |
|
|
390 | (7) |
|
|
397 | (12) |
|
|
397 | (1) |
|
Assessment of Copper Nutritional Status |
|
|
398 | (2) |
|
|
400 | (1) |
|
|
400 | (1) |
|
|
401 | (1) |
|
|
401 | (4) |
|
|
405 | (4) |
|
|
409 | (18) |
|
|
409 | (1) |
|
Dietary Sources of Selenium |
|
|
409 | (1) |
|
Determination of Selenium |
|
|
410 | (1) |
|
|
411 | (2) |
|
Platelet Glutathione Peroxidase |
|
|
413 | (1) |
|
Assessment of Selenium Status |
|
|
413 | (2) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
415 | (1) |
|
|
416 | (1) |
|
|
416 | (4) |
|
|
420 | (7) |
|
|
427 | (6) |
|
Determination of Manganese |
|
|
428 | (1) |
|
|
428 | (2) |
|
|
430 | (1) |
|
|
430 | (3) |
|
|
433 | (4) |
|
Determination of Chromium |
|
|
434 | (1) |
|
|
434 | (1) |
|
|
435 | (1) |
|
|
435 | (2) |
|
|
437 | (4) |
|
Determination of Molybdenum |
|
|
437 | (1) |
|
Molybdenum Cofactor Deficiency |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
439 | (1) |
|
|
439 | (2) |
|
|
|
Arsenic, Boron, Fluorine, Nickel, Silicon, Tin, Vanadium, and Sulfur |
|
|
441 | (6) |
|
|
441 | (1) |
|
|
441 | (1) |
|
|
441 | (1) |
|
|
442 | (1) |
|
|
442 | (1) |
|
|
442 | (1) |
|
|
442 | (1) |
|
|
442 | (1) |
|
|
443 | (4) |
Section IV Protein-Energy Malnutrition |
|
|
Protein-Energy Malnutrition |
|
|
447 | (24) |
|
|
447 | (1) |
|
Clinical Protein-Energy Malnutrition |
|
|
448 | (1) |
|
Anthropometric Parameters |
|
|
448 | (1) |
|
Biochemical Assessment of Protein-Energy Malnutrition |
|
|
448 | (1) |
|
|
449 | (1) |
|
|
450 | (1) |
|
|
450 | (1) |
|
Plasma Alkaline Ribonuclease Activity |
|
|
451 | (1) |
|
Insulin-Like Growth Factor 1 (IGF-1, Somatomedin C) |
|
|
451 | (1) |
|
|
452 | (1) |
|
|
452 | (1) |
|
Plasma Retinol-Binding Protein |
|
|
452 | (1) |
|
Plasma Transthyretin (Prealbumin; Thyroxine-Binding Prealbumin) |
|
|
453 | (1) |
|
|
453 | (1) |
|
Urinary Creatinine - Height Index |
|
|
453 | (2) |
|
Fasting Urinary Urea-Creatinine Ratio |
|
|
455 | (1) |
|
Urinary Hydroxyproline Index |
|
|
456 | (1) |
|
Pediatric Protein-Energy Malnutrition |
|
|
456 | (1) |
|
Adult Protein-Energy Malnutrition |
|
|
457 | (1) |
|
Protein-Energy Malnutrition in Geriatric Populations |
|
|
457 | (1) |
|
Hemodialysis and Protein-Energy Malnutrition |
|
|
458 | (1) |
|
Hair Changes with Protein-Energy Malnutrition |
|
|
458 | (1) |
|
|
459 | (1) |
|
|
459 | (1) |
|
|
460 | (11) |
Section V Essential Fatty Acids Deficiencies |
|
|
Essential Fatty Acids Deficiencies |
|
|
471 | (10) |
|
|
471 | (1) |
|
Dietary Sources of Essential Fatty Acids |
|
|
471 | (1) |
|
Metabolism of Linolenic Acid and Linoleic Acid |
|
|
472 | (1) |
|
Deficiency of Linoleic acid and Linolenic Acid |
|
|
473 | (1) |
|
Assessment of Essential Fatty Acid Deficiencies |
|
|
473 | (1) |
|
|
474 | (1) |
|
|
474 | (1) |
|
|
474 | (7) |
Index |
|
481 | |